Skip to main content
. 2014 Jul 3;5(4):354–357. doi: 10.1111/1759-7714.12090

Table 1.

Main clinicopathological findings of previously reported cases of primary lung carcinoma with osteoclast-like giant cells

Case No. Age/Gender Location Size (cm) Histology of main lung carcinoma Immunohistochemistry of osteoclast-like giant cells Metastasis of lung carcinoma Outcome
Surgery Autopsy
11 57/M RLL 4.5 Squamous cell carcinoma Not done None 5 years, ANED
22 60/M RLL 3 Squamous cell carcinoma Lyso- Present§ 7 days, DOD
33 60/F RLL 9 Undifferentiated carcinoma Not done None Present§ 75 days, DOD
44 61/M LUL 6 Squamous cell carcinoma CK-/EMA-/CEA-/CD68+/vim+/S-100- None 15 months, ANED
55 67/M Unknown 6.5 Sarcomatoid carcinoma CK-/EMA-/CD68+/vim+ None Unknown 19 months, DOD
65 61/F Unknown 1.5 Sarcomatoid carcinoma CK-/EMA-/CD68+/vim+ None Unknown 12 months, DOD
75 75/F Unknown 1.1 Adenocarcinoma CK-/EMA-/CD68+/vim+ None 19 months, AWD
86 58/M RUL 1.4 Large cell carcinoma CAM5.1-/CD68+ Present§ Unknown Unknown

Also containing foci of adenocarcinoma.

Including keratin AE1/AE3, keratin MAK6, and keratin CAM5.2.

§

Metastatic lesions also containing osteoclast-like giant cells. ANED, alive with no evidence of disease; AWD, alive with disease; ca, carcinoma; CK, cytokeratin; DOD, dead of disease; EMA, epithelial membrane antigen; Lyso, lysozyme; LUL, left upper lobe; RLL, right lower lobe; RUL, right upper lobe; S-100, S-100 protein; vim, vimentin.